Clozapine induced myopericarditis: Early recognition improves clinical outcome

American Journal of Therapeutics

Volumn 13, Issue 3, 2006, Pages 274-276

  Razminia, Mansour ^a   Salem, Yasser ^a   Devaki, Sivasubramaniam ^a   Shah, Nilamben ^a   Khosla, Sandeep ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Clozapine; Drug induced; Myocarditis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDITIS;

EID: 33745842230     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000212704.79248.3d     Document Type: Article

References (6)

1. Owens DG. Adverse effects of antipsychotic agents: do newer agents offer advantages? Drugs. 1996;51:895-930.
2. Conley RR. Optimizing treatment with clozapine. Clin Psychiatry. 1998;59(Suppl 3):44-48.
3. Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine Induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med. 1993;29:162-167.
4. Young CR, Bowers MB, Mazure CM. Management of adverse effects of clozapine. Schizophur Bull. 1998;24:381-390.
5. Kilian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;345:1841-1845.
6. Kagg S, Spigset O, Bate A, et al. Myocarditis related to clozapine treatment. Clin Psychopharmacol. 2001;1:382-388.